Addition of granulocyte-colony stimulating factor (G-CSF) to adjuvant treatment may increase survival in patients with operable breast cancer: Interaction of G-CSF with dormant micrometastatic breast cancer cells

Medical Hypotheses

Volumn 63, Issue 1, 2004, Pages 56-58

  Altundag, Kadri ^a   Altundag, Ozden ^b   Elkiran, Emin Tamer ^a   Cengiz, Mustafa ^a   Ozisik, Yavuz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER SURVIVAL; CELL ACTIVITY; CLINICAL TRIAL; DRUG EFFECT; HUMAN; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY;

EID: 3042726525     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.01.030     Document Type: Article

References (8)

1. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 100:2003;3983-3988
2. Webb T. Work on breast cancer stem cells raises questions about treatment strategies. J Natl Cancer Inst. 95:2003;774-775
3. Dick J.E. Breast cancer stem cells revealed. Proc Natl Acad Sci USA. 100:2003;3547-3549
4. Citron M.L., Berry D.A., Cirrincione C., et al. Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as post-operative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. J Clin Oncol. 21:2003;1431-1439
5. Welte K., Gabrilove J., Bronchud M.H., et al. Filgrastim (r-metHuG-CSF): the first 10 years. Blood. 88:1996;1907-1929
6. Braun S, Vogl FD, Schlimok G, et al. Pooled analysis of prognostic impact of bone marrow micrometastasis: 10-year survival of 4199 breast cancer patients. In: Twenty seventh annual San Antonio breast cancer symposium, San-Antonio, USA, December 7-11, 2003, Abstract no. 7
7. Wiedswang G, Borgen E, Karensen R, et al. The presence of isolated tumor cells in bone marrow three years after diagnosis in disease free breast cancer patients predicts an unfavourable outcome. In: Twenty seventh annual San Antonio breast cancer symposium, San-Antonio, USA, December 7-11, 2003, Abstract no. 8
8. Wong GYC, Yu Q, Osborne MP. Bone marrow micrometastasis is a significant predictor of long-term relapse-free survival for breast cancer by a non-proportional hazards model. In: Twenty seventh annual San Antonio breast cancer symposium, San-Antonio, USA, December 7-11, 2003, Abstract no. 420